A Novel c.1135_1138delCTGT Mutation in CLN3 Leads to Juvenile Neuronal Ceroid Lipofuscinosis

被引:7
作者
Drack, Arlene V. [1 ]
Miller, Jake N. [2 ]
Pearce, David A. [2 ,3 ]
机构
[1] Univ Iowa, Dept Ophthalmol & Visual Sci, Carver Coll Med, Iowa City, IA USA
[2] Univ S Dakota, Sanford Res, Sanford Childrens Hlth Res Ctr, Sioux Falls, SD USA
[3] Univ S Dakota, Dept Pediat, Sanford Sch Med, Sioux Falls, SD USA
关键词
Batten disease; CLN3; juvenile neuronal ceroid lipofuscinosis; neuronal ceroid lipofuscinosis; NONSENSE-MEDIATED DECAY; BATTEN-DISEASE;
D O I
10.1177/0883073813494812
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neuronal ceroid lipofuscinosis is the most common childhood neurodegenerative disorder in the world, with an incidence of 1 in 100000 live births. More than 400 mutations in at least 14 different genes are linked to multiple clinical variants. These progressive genetic disorders primarily manifest in the central nervous system due to an extensive loss of neurons, primarily in the cerebral and cerebellar cortices. Juvenile neuronal ceroid lipofuscinosis is the most common form and is primarily due to mutations in CLN3, which encodes a protein of unknown function. The most common such mutation in CLN3 is a 1.02-kb deletion that results in a frameshift and subsequent premature termination codon. Here we describe a patient with juvenile neuronal ceroid lipofuscinosis who has a novel c.1135_1138delCTGT mutation in CLN3. This deletion induces a frameshift and premature termination codon in CLN3 messenger ribonucleic acid that is likely recognized by nonsense-mediated decay and degraded, subsequently leading to decreased CLN3 protein abundance.
引用
收藏
页码:1112 / 1116
页数:5
相关论文
共 14 条
  • [1] Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models
    Chan, Chun-Hung
    Mitchison, Hannah M.
    Pearce, David A.
    [J]. HUMAN MOLECULAR GENETICS, 2008, 17 (21) : 3332 - 3339
  • [2] Characterization of Cln3p, the gene product responsible for juvenile neuronal ceroid lipofuscinosis, as a lysosomal integral membrane glycoprotein
    Ezaki, J
    Takeda-Ezaki, M
    Koike, M
    Ohsawa, Y
    Taka, H
    Mineki, R
    Murayama, K
    Uchiyama, Y
    Ueno, T
    Kominami, E
    [J]. JOURNAL OF NEUROCHEMISTRY, 2003, 87 (05) : 1296 - 1308
  • [3] Haltia M, 2003, J NEUROPATH EXP NEUR, V62, P1
  • [4] Nonsense-mediated decay approaches the clinic
    Holbrook, JA
    Neu-Yilik, G
    Hentze, MW
    Kulozik, AE
    [J]. NATURE GENETICS, 2004, 36 (08) : 801 - 808
  • [5] Neuronal ceroid lipofuscinoses
    Jalanko, Anu
    Braulke, Thomas
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2009, 1793 (04): : 697 - 709
  • [6] Update of the Mutation Spectrum and Clinical Correlations of over 360 Mutations in Eight Genes that Underlie the Neuronal Ceroid Lipofuscinoses
    Kousi, Maria
    Lehesjoki, Anna-Elina
    Mole, Sara E.
    [J]. HUMAN MUTATION, 2012, 33 (01) : 42 - 63
  • [7] Two motifs target Batten disease protein CLN3 to lysosomes in transfected nonneuronal and neuronal cells
    Kyttälä, A
    Ihrke, G
    Vesa, J
    Schell, MJ
    Luzio, JP
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2004, 15 (03) : 1313 - 1323
  • [8] Pharmaceutical therapies to recode nonsense mutations in inherited diseases
    Lee, Hui-Ling Rose
    Dougherty, Joseph P.
    [J]. PHARMACOLOGY & THERAPEUTICS, 2012, 136 (02) : 227 - 266
  • [9] ISOLATION OF A NOVEL GENE UNDERLYING BATTEN-DISEASE, CLN3
    LERNER, TJ
    BOUSTANY, RMN
    ANDERSON, JW
    DARIGO, KL
    SCHLUMPF, K
    BUCKLER, AJ
    GUSELLA, JF
    HAINES, JL
    KREMMIDIOTIS, G
    LENSINK, IL
    SUTHERLAND, GR
    CALLEN, DF
    TASCHNER, PEM
    DEVOS, N
    VANOMMEN, GJB
    BREUNING, MH
    DOGGETT, NA
    MEINCKE, LJ
    LIU, ZY
    GOODWIN, LA
    TESMER, JG
    MITCHISON, HM
    ORAWE, AM
    MUNROE, PB
    JARVELA, IE
    GARDINER, RM
    MOLE, SE
    [J]. CELL, 1995, 82 (06) : 949 - 957
  • [10] The role of nonsense-mediated decay in neuronal ceroid lipofuscinosis
    Miller, Jake N.
    Chan, Chun-Hung
    Pearce, David A.
    [J]. HUMAN MOLECULAR GENETICS, 2013, 22 (13) : 2723 - 2734